|
USP38 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.2417999999953E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.423700E-04 |
| Normal-vs-Stage2 |
3.579900E-02 |
| Normal-vs-Stage3 |
3.56080000000203E-05 |
| Normal-vs-Stage4 |
3.84060000002684E-06 |
| Stage1-vs-Stage2 |
5.555200E-01 |
| Stage1-vs-Stage3 |
1.391010E-01 |
| Stage1-vs-Stage4 |
2.470300E-02 |
| Stage2-vs-Stage3 |
1.302040E-01 |
| Stage2-vs-Stage4 |
4.511700E-02 |
| Stage3-vs-Stage4 |
4.316600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.66219999999862E-05 |
| Normal-vs-AfricanAmerican |
1.019170E-01 |
| Normal-vs-Asian |
1.775590E-04 |
| Caucasian-vs-AfricanAmerican |
2.804000E-01 |
| Caucasian-vs-Asian |
5.331400E-01 |
| AfricanAmerican-vs-Asian |
1.528380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.28110000000315E-05 |
| Normal-vs-Female |
2.247900E-04 |
| Male-vs-Female |
2.710400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.784800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.55010000000489E-05 |
| Normal-vs-Age(61-80Yrs) |
1.240470E-04 |
| Normal-vs-Age(81-100Yrs) |
1.293010E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.187400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.618600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.540400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.254400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.559200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.086400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.482400E-02 |
| Classical-VS-Follicular |
5.208000E-01 |
| Classical-VS-Other |
1.503020E-01 |
| Classical-VS-Normal |
9.188300E-04 |
| Tall-VS-Follicular |
1.838190E-01 |
| Tall-VS-Other |
4.835200E-01 |
| Tall-VS-Normal |
5.72129999999449E-05 |
| Follicular-VS-Other |
2.593200E-01 |
| Follicular-VS-Normal |
1.723040E-03 |
| Other-VS-Normal |
8.257000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.008900E-04 |
| Normal-vs-N1 |
1.55661999999834E-05 |
| N0-vs-N1 |
9.176100E-02 |
|
|
